ReviewJHEP reports : innovation in hepatology2026
The use of FGF21 analogues in MASH and MASH cirrhosis - metabolic master regulators or liver-specific mechanisms?
A G Holleboom et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it